CA2374440A1 - Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede - Google Patents

Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede Download PDF

Info

Publication number
CA2374440A1
CA2374440A1 CA002374440A CA2374440A CA2374440A1 CA 2374440 A1 CA2374440 A1 CA 2374440A1 CA 002374440 A CA002374440 A CA 002374440A CA 2374440 A CA2374440 A CA 2374440A CA 2374440 A1 CA2374440 A1 CA 2374440A1
Authority
CA
Canada
Prior art keywords
seq
drb1
allele
probe
alleles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002374440A
Other languages
English (en)
French (fr)
Inventor
Bruno Mougin
Jean-Marie Tiercy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26234969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2374440(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9906599A external-priority patent/FR2793808B1/fr
Application filed by Individual filed Critical Individual
Publication of CA2374440A1 publication Critical patent/CA2374440A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002374440A 1999-05-20 2000-05-19 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede Abandoned CA2374440A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR99/06599 1999-05-20
FR9906599A FR2793808B1 (fr) 1999-05-20 1999-05-20 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie
FR9915314A FR2793809B1 (fr) 1999-05-20 1999-12-06 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede
FR99/15314 1999-12-06
PCT/FR2000/001385 WO2000071750A1 (fr) 1999-05-20 2000-05-19 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede

Publications (1)

Publication Number Publication Date
CA2374440A1 true CA2374440A1 (fr) 2000-11-30

Family

ID=26234969

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002374440A Abandoned CA2374440A1 (fr) 1999-05-20 2000-05-19 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede

Country Status (12)

Country Link
US (1) US7060438B1 (enExample)
EP (1) EP1179091B2 (enExample)
JP (1) JP2003500067A (enExample)
CN (1) CN1351672A (enExample)
AT (1) ATE279535T1 (enExample)
AU (1) AU772175B2 (enExample)
BR (1) BR0010739A (enExample)
CA (1) CA2374440A1 (enExample)
DE (1) DE60014887T3 (enExample)
ES (1) ES2230109T5 (enExample)
FR (1) FR2793809B1 (enExample)
WO (1) WO2000071750A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829580B1 (fr) 2001-09-07 2004-02-13 Bio Merieux Procede de lecture, de detection ou de quantification, hybrides ou complexes utilises dans ce procede et biopuce mettant en oeuvre ledit procede
WO2004047007A1 (en) 2002-11-15 2004-06-03 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
EP1536021A1 (en) * 2003-11-27 2005-06-01 Consortium National de Recherche en Genomique (CNRG) Method for HLA typing
US7848889B2 (en) * 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
FR2881437B1 (fr) 2005-01-31 2010-11-19 Biomerieux Sa Procede pour le diagnostic/pronostic d'un syndrome septique
FR2906537A1 (fr) 2006-09-28 2008-04-04 Biomerieux Sa Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie
US20130096024A1 (en) * 2010-04-27 2013-04-18 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Method for detecting the susceptibility to develop adverse side effects related to bioimplants
EP2576815B1 (en) 2010-06-04 2018-02-14 Biomérieux Method for the prognosis of colorectal cancer
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
WO2012129758A1 (en) 2011-03-25 2012-10-04 Biomerieux Method and kit for determining in vitro probability for individual to suffer from colorectal cancer
EP3000897B1 (en) 2013-05-21 2019-10-16 Biomérieux Colorectal cancer prognosis agent kit
EP3620984B1 (en) 2018-09-06 2024-04-10 Accenture Global Solutions Limited Digital quality control using computer visioning with deep learning
WO2025172242A1 (en) 2024-02-13 2025-08-21 bioMérieux Method of assessing the risk of death of a patient

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567809A (en) * 1986-03-13 1996-10-22 Hoffmann-La Roche Inc. Methods and reagents for HLA DRbeta DNA typing
US5468611A (en) * 1990-06-27 1995-11-21 The Blood Center Research Foundation, Inc. Method for HLA typing
NL9002259A (nl) * 1990-10-17 1992-05-18 Eurodiagnostics B V Werkwijze voor het bepalen van een genotype door het vergelijken van de nucleotidensequentie van leden van een genfamilie, alsmede kit voor het opsporen van genetische variaties.
GB9024005D0 (en) 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid
FR2679252B1 (fr) * 1991-07-17 1993-12-10 Bio Merieux Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes.
US5976789A (en) * 1991-07-17 1999-11-02 Bio Merieux System of probes enabling HLA-DR typing to be performed, and typing method using said probes
JPH0690757A (ja) * 1991-08-23 1994-04-05 Kitasato Inst:The Ｈｌａ−ｄｒタイピング用塩基配列群とそれを用いた ｈｌａ−ｄｒタイピング法
JPH08308596A (ja) * 1995-03-10 1996-11-26 Wakunaga Pharmaceut Co Ltd Ｈｌａの検出
US5939542A (en) 1995-03-10 1999-08-17 Wakunaga Seiyaku Kabushiki Kaisha Detection of HLA-DR
WO1997020070A1 (en) * 1995-11-29 1997-06-05 The Anthony Nolan Bone Marrow Trust Methods for separating and/or identifying dna molecules
FR2749308B1 (fr) * 1996-06-03 1998-07-24 Bio Merieux Sondes nucleotidiques et procede pour determiner le typage hla dqb1
AU6321998A (en) * 1997-02-11 1998-08-26 William H. Hildebrand Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing
EP0887423A1 (en) * 1997-06-26 1998-12-30 Biotest Ag A method for determining the Histocompatibility locus antigen class II
JP2001512694A (ja) * 1997-08-11 2001-08-28 ビジブル・ジェネティクス・インコーポレーテッド Ｄｎａのｈｌａクラスｉタイプを決定するための方法およびキット
US5910413A (en) * 1997-10-10 1999-06-08 Visible Genetics, Inc. Method and kit for amplification, sequencing and typing of classical HLA class I genes

Also Published As

Publication number Publication date
EP1179091A1 (fr) 2002-02-13
DE60014887T3 (de) 2009-09-24
AU772175B2 (en) 2004-04-08
ATE279535T1 (de) 2004-10-15
EP1179091B2 (fr) 2009-02-25
ES2230109T3 (es) 2005-05-01
EP1179091B1 (fr) 2004-10-13
BR0010739A (pt) 2002-02-19
AU4766000A (en) 2000-12-12
JP2003500067A (ja) 2003-01-07
FR2793809B1 (fr) 2006-07-28
FR2793809A1 (fr) 2000-11-24
US7060438B1 (en) 2006-06-13
WO2000071750A1 (fr) 2000-11-30
CN1351672A (zh) 2002-05-29
ES2230109T5 (es) 2009-06-05
DE60014887T2 (de) 2005-10-13
DE60014887D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
AU2009244634B2 (en) Method for evaluating and comparing immunorepertoires
EP1179091B1 (fr) Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede
Doxiadis et al. Haplotype diversity generated by ancient recombination-like events in the MHC of Indian rhesus macaques
Conrad et al. Microsatellite polymorphism in the sexually transmitted human pathogen Trichomonas vaginalis indicates a genetically diverse parasite
WO1999061661A1 (fr) Procede d'amplification d'au moins une sequence nucleotidique particuliere et amorces de mise en oeuvre
EP0772694A1 (fr) Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes
EP0549776B1 (fr) Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes
EP1334211B1 (fr) Procede d'analyse de la predisposition genetique d'un patient au diabete insulino-dependant, dispositif et jeu d'amorces
TW201300528A (zh) Ｈｌａ－ｄｑｂ１基因分型的方法及其相關引子
FR2793808A1 (fr) Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie
EP0910667A1 (fr) Sondes nucleotidiques et procede pour determiner le typage hla dqb1
WO2008059165A2 (fr) Methodes et outils pour determiner l'origine d'un sujet
WO2021152257A1 (fr) Procede de genotypage hla simple et rapide
Swelsen et al. Sequence-based typing of the HLA-A10/A19 group and confirmation of a pseudogene coamplified with A* 3401
Lee et al. Development and clinical evaluation of a microarray for HLA‐A and‐DRB1 genotyping
EP2094865B1 (fr) Procede d'identification moleculaire et genotypage des bacteries du complexe mycobacterium tuberculosis
Sun et al. Identification and frequency of a novel HLA-A allele, A* 110104

Legal Events

Date Code Title Description
FZDE Discontinued